Caption Management, LLC Galapagos Nv Put Options Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$34.17 - $42.98 $512,550 - $644,700	15,000 Added 50.0%	45,000 $1.55 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $44.52 $1.19 Million - $1.42 Million	-31,900 Reduced 51.53%	30,000 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $2.32 Million - $2.88 Million	61,900 New	61,900 $2.75 Million
Q1 2022 May 13, 2022	SELL	$51.32 - $68.5 $769,800 - $1.03 Million	-15,000 Reduced 33.33%	30,000 $1.86 Million
Q4 2021 Feb 11, 2022	SELL	$47.03 - $57.12 $1.65 Million - $2 Million	-35,000 Reduced 43.75%	45,000 $2.48 Million
Q3 2021 Nov 12, 2021	SELL	$52.17 - $70.2 $4.67 Million - $6.28 Million	-89,500 Reduced 52.8%	80,000 $4.21 Million
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $275,440 - $333,360	-4,000 Reduced 2.31%	169,500 $11.7 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $4.19 Million - $6.16 Million	55,000 Added 46.41%	173,500 $13.4 Million
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $11.5 Million - $17.6 Million	118,500 New	118,500 $11.7 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.